These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 886192)

  • 21. H-2 restriction of adoptive immunotherapy of advanced tumors.
    Greenberg PD; Cheever MA; Fefer A
    J Immunol; 1981 Jun; 126(6):2100-3. PubMed ID: 6453154
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.
    Wahren B
    J Natl Cancer Inst; 1968 Oct; 41(4):931-8. PubMed ID: 5693664
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F; Genovesi EV; Collins JJ
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapy of murine leukemia. I. Protection against Friend leukemia virus-induced disease by passive serum therapy.
    Collins JJ; Sanfilippo F; Tsong-Chou L; Ishizaki R; Metzgar RS
    Int J Cancer; 1978 Jan; 21(1):51-61. PubMed ID: 624599
    [No Abstract]   [Full Text] [Related]  

  • 27. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1980 Aug; 125(2):711-4. PubMed ID: 6156213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy in leukemia. Experimental and clinical approaches.
    Mathé G
    Ser Haematol; 1972; 5(5):66-86. PubMed ID: 4151467
    [No Abstract]   [Full Text] [Related]  

  • 29. Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.
    Matis LA; Shu S; Groves ES; Zinn S; Chou T; Kruisbeek AM; Rosenstein M; Rosenberg SA
    J Immunol; 1986 May; 136(9):3496-501. PubMed ID: 2420893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cyclophosphamide on Friend virus leukemogenesis in virus-sensitive and virus-resistant mice.
    Raikow RB; OKunewick JP; Buffo MJ; Kociban DL
    Cancer Res; 1985 Feb; 45(2):555-7. PubMed ID: 3967230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody.
    Weiner RS; Hubbard JD; Mardiney MR
    J Natl Cancer Inst; 1972 Oct; 49(4):1063-70. PubMed ID: 4117316
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 33. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
    Kitagawa M; Matsubara O; Kasuga T
    Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB; Fass L; Fefer A
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Moloney virus-induced leukemia with cyclophosphamide and specifically sensitized allogeneic cells.
    Glynn JP; Kende M
    Cancer Res; 1971 Oct; 31(10):1383-8. PubMed ID: 5095130
    [No Abstract]   [Full Text] [Related]  

  • 36. [Induction of the antileukemic activity in nonimmune allogeneic splenocytes using spleen hemoregulators].
    Svirnovskiĭ AI; Shimanskaia TV; Bakun AV; Ageĭchik VM
    Eksp Onkol; 1988; 10(5):57-61. PubMed ID: 3208692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of established Friend virus leukemia by statolon. IV. Role of humoral antibody in the development of a dormant infection.
    Wheelock EF; Toy ST; Caroline NL; Sibal LR; Fink MA; Beverley PC; Allison AC
    J Natl Cancer Inst; 1972 Mar; 48(3):665-73. PubMed ID: 5062046
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy in Friend virus leukemia. I. Prevention of Friend leukemia in the offspring of immunized mothers.
    Wahren B
    J Natl Cancer Inst; 1968 Oct; 41(4):923-9. PubMed ID: 5693663
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
    J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral regulation of cell-mediated immunity to syngeneic tumor.
    Ting CC
    Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.